Cph was isolated from neoplastic Syrian hamster embryo ®broblasts initiated by 3-methylcholanthrene (MCA), and was shown to be a single copy gene in the hamster genome, conserved from yeast to human cells, expressed in fetal cells and most adult tissues, and acting synergistically with H-ras in the transformation of murine NIH3T3 ®broblasts. We have now isolated Syrian hamster full-length cDNAs for the cph oncogene and proto-oncogene. Nucleotide sequence analysis revealed that cph was activated in MCA-treated cells by a point-mutational deletion at codon 214, which caused a shift in the normal open reading frame (ORF) and brought a translation termination codon 33 amino acids downstream. While proto-cph encodes a protein (pcph) of 469 amino acids, cph encodes a truncated protein (cph) of 246 amino acids with a new, hydrophobic C-terminus. Similar mechanisms activated cph in other MCA-treated Syrian hamster cells. The cph and proto-cph proteins have partial sequence homology with two protein families: GDP/GTP exchange factors and nucleotide phosphohydrolases. In vitro translated, gel-puri®ed cph proteins did not catalyze nucleotide exchange for H-ras, but were able to bind nucleotide phosphates, in particular ribonucleotide diphosphates such as UDP and GDP. Steady-state levels of cph mRNA increased 6.7-fold in hamster neoplastic cells, relative to a 2.2-fold increase in normal cells, when they were subjected to a nutritional stress such as serum deprivation. Moreover, cphtransformed NIH3T3 cells showed increased survival to various forms of stress (serum starvation, hyperthermia, ionizing radiation), strongly suggesting that cph participates in cellular mechanisms of response to stress.
Introduction
Neoplastic transformation results from the aberrant regulation of mechanisms of cellular proliferation, dierentiation and/or apoptosis. Detection, isolation and characterization of the proteins involved in each process are required for a comprehensive understanding of the molecular basis of cell transformation. Carcinogenesis is a multistep process that involves alterations of multiple genes and cellular regulatory systems (Farber, 1984; Boyd and Barrett, 1990) . In vivo and in vitro carcinogenesis studies have demonstrated that mechanisms such as oncogene activation, tumor suppressor gene loss or functional inactivation, and growth factor overproduction have been associated with the onset and development of neoplasia (Bishop, 1987; Weinberg, 1989; Fearon and Vogelstein, 1990; Harris, 1991; Broach and Levine, 1997) .
The study of the molecular events involved in the malignant transformation of human cells has been limited due to their intrinsic resistance to neoplastic conversion in vitro by physical or chemical carcinogens (DiPaolo, 1983) . Therefore, identi®cation of the molecular alterations caused on cellular genes by exposure of primary animal cell cultures to diverse carcinogens is essential for understanding the mechanisms of malignant conversion. Consequently, diverse in vivo and in vitro animal models have been used to study the role of oncogenes in carcinogenesis. Most oncogenes have been isolated by transfection into NIH3T3 cells (Wigler et al., 1979; Toksoz and Williams, 1994) . While the majority of oncogenes detected by this method in DNAs from either tumors induced experimentally in animals or naturally occurring in humans are members of the ras gene family (Barbacid, 1987; Balmain and Brown, 1988; Bos, 1989) , transforming genes other than ras (i.e. met, trk, dbl, raf, vav, lbc) have been isolated also. Some non-ras oncogenes such as raf (Kasid et al., 1987) , members of the myc family (Brooks et al., 1987) , or neu/erbB2 (Slamon et al., 1987) , have been positively associated with speci®c human malignancies.
Our laboratory has worked on the molecular analysis of the Syrian hamster embryo cell transformation system (Berwald and Sach, 1965) . This model uses chemically initiated neoplastic hamster embryo cells as an alternative in vitro system the characteristics of which make it relevant for studies of the cellular and molecular biology of human carcinogenesis (DiPaolo et al., 1969a (DiPaolo et al., ,b, 1971 (DiPaolo et al., , 1986 . The treatment of Syrian hamster cells in vitro with chemical or physical carcinogens has been used as the experimental model in other laboratories, and proved to be ecient for the detection of non-ras transforming genes (Borek et al., 1987; Gilmer et al., 1988) . We demonstrated that ras activation is a low frequency event in this system (Notario et al., 1990) , and established the participation of oncogenes and tumor suppressor genes in the carcinogenesis process (Notario et al., 1990; Albor et al., 1994a,b) . Treatment of Syrian hamster embryo ®broblasts with a single dose of MCA caused the activation of the transforming potential of cellular sequences (Notario et al., 1990) , which were subsequently isolated by cosmid rescue techniques, and further identi®ed as a novel oncogene, termed cph because of its involvement in the carcinogenic progression of hamster embryo cells. The cloned cph oncogene was able to transform NIH3T3 cells and showed a synergistic eect with the human H-ras oncogene in co-transfection assays (Velasco et al., 1994) . Furthermore, we showed that cph is conserved in eukaryotic cells, from yeast to humans, and is expressed in a broad range of tissue types and developmental stages, from embryo cells to adult tissues (Velasco et al., 1996) , suggesting that the normal function of the cph protein product(s) may be essential for metabolic processes involved in the regulation of cell proliferation and survival.
In order to identify pathways involved in the neoplastic conversion of hamster cells expressing the activated cph oncogene, we investigated the presence of mitogenic factors in conditional medium of the hamster neoplastic cells. These studies showed that expression of the cph oncogene in Syrian hamster and mouse cells leads to the establishment of an autocrine loop mediated by the simultaneous secretion of an a2b-neuregulin and the increased expression of the erbB2 or erbB4 receptors (Avila et al., 1995; Velasco et al., 1998) . These results support the notion that autocrine neuregulin signaling plays an important role in maintaining the transformed phenotype by providing a growth advantage to the cph-transformed cells.
We describe now the isolation and sequencing of full-length cDNAs for the cph oncogene and protooncogene (proto-cph). Nucleotide sequence analysis con®rmed that cph is indeed a novel gene. Comparison of the cph and proto-cph nucleotide sequences demonstrated that cph was activated by a pointmutational deletion within the coding region of the proto-oncogene. This single base-pair change causes a shift in the normal ORF and translation of the mutated protein from the new predicted ORF terminates 33 residues downstream. Therefore, the cph oncoprotein is a truncated form of the normal (246 vs 469 amino acids) with an additional rather hydrophobic C-terminal tail. Both cph and pcph proteins share partial homology to GTP/GDP exchange factors and nucleotide phosphatases. Biochemical analyses of in vitro translated cph and pcph proteins and functional analyses of cells transformed by cph or transfected with proto-cph expression vectors indicate that (i) the normal and mutated products are ribonucleotide-binding proteins but do not catalyze nucleotide exchange on the H-ras protein, (ii) steadystate levels of proto-cph and, particularly, cph mRNA are upregulated in cells maintained in culture under serum deprivation; and (iii) the cph oncoprotein provides the cells with enhanced stress-survival functions. These results suggest that cph participates in cellular mechanisms of response to stress.
Results

Cloning of the cph and proto-cph cDNAs
Screening of a l-ZAP-II cDNA library prepared from neoplastic Syrian hamster 81C39 cells with a cphspeci®c genomic probe (S6, Figure 1a ) resulted in the isolation of three bacteriophage clones that were in vivo excised to generate the plasmid clones pB1-8, pB1-13 and pB1-19. Clones 8 and 19 contained inserts of about 1.7 kb, whereas clone 13 had an insert of about 2.1 kb. Restriction endonuclease analyses demonstrated that clones 8 and 19 had identical restriction maps ( Figure 1a ). Clone 13 shared some fragments with clones 8 and 19, but had additional cleavage sites for some restriction endonucleases (i.e. Pvu II). Nucleotide sequence analysis of the 3' end of the three inserts con®rmed that clones 8 and 19 were identical and showed that clone 13 had undergone a major rearrangement (data not shown), most likely during in vivo excision from the bacteriophage vector. Clone pB1-19 was selected for further characterization. Figure 1 Cloning and characterization of the cph cDNA from neoplastic 81C39 cells. A cDNA library was prepared into the l-ZAP-II vector using poly (A + ) RNA from cells (81C39) expressing the cph oncogene. A genomic fragment (S6) from the cph oncogene (a, B-1, Velasco et al., 1994) , free of Syrian hamster repetitive sequences (RS and G1), was used to screen the library. The bottom of a depicts the structure of the full-length cph cDNA clone pB1-19; the location of the sequences shared with the S6 cloning probe is shown, and the open reading frame is shadowed. Localization of recognition sites for major restriction endonucleases are indicated (B, BamHI; P, PvuII; S, SacI; R, EcoRI; X, XhoI). Molecular size units are indicated by horizontal bars. b shows that both the insert from clone pB1-19 (19 lane) and the S6 cloning probe (S6 lane) identi®ed the same cph characteristic transcripts (Velasco et al., 1996) in mRNA preparations from 81C39 cells. Hybridization with b-actin was used as loading control
The insert of pB1-19 was puri®ed and utilized as the probe in northern analyses of Syrian hamster poly (A + ) RNA. Results showed that it recognized the same three transcript species of about 1.8, 3.4 and 5.0 kb (Velasco et al., 1994 (Velasco et al., , 1996 detected in Syrian hamster cells and most adult tissues with the S6 (Figure 1a ) genomic probe used for cDNA cloning (Figure 1b) . The insert of pB1-19 was sequenced in its entirety (Figure 2 ). Computer analysis of the nucleotide sequence showed that the actual length of the pB1-19 insert was 1749 bp, and predicted the existence of an uninterrupted ORF between nucleotide positions 77 and 817, which would have coding capacity for the synthesis of a protein of 246 amino acids, and a long (932 bp) 3' untranslated region (Figures 1b and 2 ). Nucleotide sequence comparisons performed with the program FastA (Pearson and Lipmann, 1988) showed that cph did not share any signi®cant global homology with sequences deposited in the GenBank and EMBL databases, indicating that cph de®nes a novel class of genes with oncogenic potential.
Screening of a l-ZAP-II cDNA library prepared from normal (84-3) Syrian hamster cells using the pB1-19 insert as the probe yielded four independent clones. Clone pB1-843, the one with the longest insert (about 1.8 kb) was chosen for further characterization. The pB1-843 insert was 1750 bp long (the 5' untranslated region was 23 nucleotides longer than in the cph cDNA), its restriction map was identical to that of the cph cDNA in pB1-19, and also recognized the three typical cph transcripts (data not shown). Because both cDNAs represented the 1.8 kb cph transcript, these data con®rmed preliminary evidence (Velasco et al., 1994) that cph activation was not due to any gross rearrangement of the proto-cph gene.
Transforming and tumorigenic potential of the cph cDNA
In order to determine whether the cloned cph oncogene cDNA had the transforming potential detected previously for the cph gene (Velasco et al., 1994) , a cph expression vector was constructed by ligating directionally the EcoRI ± XhoI insert of pB1-19 into the EcoRI and XhoI sites of pCDNA3. In this construct, designated pCMV-CPH, transcription of the cph insert is driven by the CMV immediate early promoter/enhancer sequences. A similar construct, designated pCMV-PCPH, was prepared with the proto-cph cDNA by ligating the insert of pB1-843 directionally into pCDNA3. Puri®ed DNA (1 mg) from pCMV-CPH were transfected into NIH3T3 cells, and the cultures were monitored for the appearance of foci of morphologically transformed cells. Control transfections were performed with DNA from pCMV-PCPH and pCDNA3. Transformed foci (about 50 per plate) were easily detectable 18 ± 24 days post-transfection, in three replicated experiments, in the dishes with cells transfected with the cph cDNA. No foci could be detected even after 5 weeks in dishes with cells Figure 2 Nucleotide sequence of the cph cDNA and deduced amino acid sequence of the cph oncoprotein. The nucleotide sequence shown corresponds to the entire insert cloned in pB1-19 and the nucleotide positions are indicated on the left. The primary structure deduced for the cph protein product is shown below the nucleotide sequence using the single letter code for amino acids. Translation initiation and termination at the underlined codons in capitals de®ne an ORF with coding capacity for a protein of 246 residues, followed by a very long 3' untranslated region. An upstream, in frame translation termination codon is underlined. The truncation point relative to the normal protein is indicated by an arrow, and the new C-terminal amino acids are underlined. The nucleotide sequences of cph and proto-cph have been deposited in GenBank (accession numbers: AF084568 and AF084569) transfected with either the proto-cph cDNA or the empty pCDNA3 vector. Relative to non-transformed cells (Figure 3a) , foci of cells transformed by the cph cDNA showed morphological alterations similar to those described for NIH3T3 cells transformed by the activated cph gene (Figure 3b , Velasco et al., 1994) .
NIH3T3 cells are known to undergo spontaneous transformation when cultured at high con¯uency for extended periods of time. Because of the relatively late appearance of foci in the cultures of cph-transfected cells, there was a possibility that they might be spontaneous NIH3T3 transformants. However, the ability of about 85% of the cph foci to grow ( Figure  3c) in the presence of G-418 (400 mg/ml), a property provided by the presence of a NEO expression cassette in the pCDNA3 vector, demonstrated that indeed the cells had taken up the cph expression construct. NIH3T3 cells transfected with pCMV-PCPH or pCDNA3 were also selected in the presence of G-418 and the G-418 resistant colonies were expanded so that they could be used as controls for the cph-transformed cells. Cells from all cph foci tested expressed transcripts derived from the transfected CMV-cph cDNA construct ( Figure 4 , lanes 1 ± 6), whereas no expression could be detected in vector-transfected cells (Figure 4 , lane V). These results demonstrated conclusively that cph foci did not arise spontaneously.
The malignant phenotype of the cph-transformed cells was ®rst assessed by their ability to grow in semisolid medium. Triplicated soft-agar cultures of cph-transformed cells showed about 50 colonies within 2 weeks after seeding, whereas only 1 or 2 occasional colonies were observed in cultures of NIH3T3 transfected with pCMV-PCPH or pCDNA3. The cphderived soft-agar colonies continued to proliferate in an anchorage-independent manner, remaining viable for more than 4 weeks in culture, and were readily expanded into monolayer cultures ( Figure 3d ). Tumorigenesis assays were performed as the second approach to con®rm that cph-transformed cells had acquired a fully malignant phenotype. Cph-transformed cells, before and after selection in soft-agar, were injected (10 7 cells per injection site) subcutaneously into both rear¯anks of ®ve female nude mice. Additional groups of ®ve mice each were similarly injected with cells transfected with the proto-cph expression construct or with the pCDNA3 vector. Tumors developed within 4 weeks at all injections sites in all animals receiving cphtransformed cells, whereas no tumors developed in animals injected with proto-cph-or pCDNA3-transfected cells. Histopathological examination showed that cph-transformed cells gave rise to spindle cell tumors with morphologic features in keeping with ®brosarcoma. Tumors showed a signi®cant proportion of mitosis (2 ± 4 per ®eld using the 406objective), and were composed by cells with elongated cytoplasms and oval to elongated nuclei, mostly arranged in interlacing fascicles (Figure 3e and f).
The cph oncogene is activated by a point mutational deletion
Comparisons between the nucleotide sequences of the cph and proto-cph cDNAs showed that the latter contained only one nucleotide dierence: a point mutational deletion within the coding region of the proto-oncogene (Figure 5a ). This single base-pair change had important consequences, because it caused a shift in the ORF and translation of the mutated protein from the new predicted ORF would terminate 34 codons downstream. Therefore, the cph oncoprotein would be a truncated form of the normal pcph protein (246 vs 469 amino acids); furthermore, the cph protein would have a new, rather hydrophobic C-terminal tail, not present in the normal polypeptide ( Figure 5b ). In vitro coupled transcription/translation (TNT) experiments ( Figure 5c ) demonstrated that the normal and mutated ORFs indeed have the capacity to encode the predicted proteins. Along with the data on the transforming and tumorigenic activity of the cph cDNA described above, these results showed that, although Syrian hamster cells express three cph transcripts (1, 8, 3.4 and 5.0 kb), the mutation detected in the cDNA of the smallest species was sucient to cause transformation.
We then tried to determine whether cph had been activated by this same mechanism in other Syrian hamster cell lines initiated with the same carcinogen and positive in the NIH3T3 foci formation assay (Notario et al., 1990) . Using RT ± PCR and TA-cloning we isolated a 600 bp fragment of the cph cDNAs from other six cell lines. The PCR primers were designed so that the original mutation detected in the cph oncogene from 81C39 cells was located in the middle of the ampli®ed fragment. Sequencing of these fragments identi®ed ®ve types of mutations that, interestingly, aected`T' residues in all cases and were clustered within a small region of the cDNA (Figure 6a ). One of the mutations (mutant 1, Figure 6a ) resulted from some reorganization because after the deleted T, the sequence was absolutely dierent from that of cph. A second mutation (mutant 2) was a C to T transition which would substitute the Pro residue at position 211 for Leu. The three other mutations, all deletions, caused frame-shifts which would produce proteins that terminated at the same stop codon, although the lengths of their new C-terminal tails were dierent (Figure 6b ) in the three cases. Whether all these mutations derive from the same transcript species in all cell lines tested, and the reason for their clustering and aecting only`T' residues remain to be elucidated.
The cph proteins share partial homology with guanine nucleotide exchange factors
In order to gain some mechanistic and/or functional insight on cph, the amino acid sequence of the cph and pcph proteins deduced from the nucleotide sequence of their cDNAs were analysed for the existence of homologies with known proteins. Comparative analyses with translated sequences in the GenBank, EMBL, SwissProt and Pir-Prot protein databases detected a moderate homology with a group of proteins ( Figure 7a ) the prototype of which is that encoded by the human proto-dbl cDNA (Ron et al., 1988) . In the case of dbl, the homology corresponded to a 231 amino acid stretch of the proto-dbl protein de®ned as the dbl-homologous (DH) domain and almost the entire sequence of the cph protein, and the N-terminal half of the pcph protein. The presence of the DH domain was a structural feature common to all other proteins showing some homology with the cph and pcph proteins. The identity between the DHdomains of the proto-dbl and the cph and pcph proteins was 22.7%, a level of similarity in agreement with those described for other proteins in which the presence of the DH domain has been identi®ed (Hart et al., 1994; Quilliam et al., 1995) . Furthermore, when conservative substitutions between amino acids were taken into account, the similarity between cph and dbl and related proteins reached nearly 50%. The DH domain has been identi®ed primarily within a group of proteins, designated GDP/GTP exchange factors Analyses of other Syrian hamster cells initiated with MCA showed that (a) cph is frequently activated by point mutational deletions or substitutions (*, 1 ± 5) aecting primarilỳ T' residues within a 100 bp region of the cph proto-oncogene (nucleotide positions, nt, 669 ± 755). The majority of the mutations (3, 4 and 5) result in the generation of truncated cph proteins (b) with the addition of hydrophobic C-terminal tails, which overlap partially among the various mutants. Only one mutation (2) involved a nucleotide substitution, and another (1) showed a major rearrangement starting at nt 670 (arrows) (GEFs), which regulate the transition of small GTPbinding proteins, such as the ras proteins, from the inactive, GDP-bound state, to the active, GTP bound state (Hall, 1990; Quilliam et al., 1995) . Figure 7a shows the homology of cph to a region within the SRC3 subdomain of DH (Boguski and McCormick, 1993) which is particularly well conserved among GEFs. These results suggested the possibility that the cph and pcph proteins were novel GEFs.
The cph and pcph proteins do not catalyze GDP/GTP exchange activity of H-ras in vitro
As indicated above, we had shown by cotransfection experiments that cph synergized with the H-ras oncogene for the transformation of NIH3T3 cells (Velasco et al., 1994) . The presence of a DH domain in the cph protein provided a potential lead to understand the cph/ras synergism. Thus, we hypothesized that cph encoded a GEF for H-ras. Bacterial recombinant H-ras p21 protein was loaded with [ 3 H]GDP and immobilized on nitrocellulose membranes. The cph and pcph proteins were synthesized in vitro using TNT methodology, and were used either as crude extracts or after gel puri®cation for exchange activity assays. The equilibrium between binding and dissociation of the radiolabel was controlled by the addition to the reaction of an excess of cold guanine nucleotides, and the exchange of guanine nucleotides was measured by the relative percentage of radiolabel released from the immobilized p21 protein. These experiments were repeated ®ve times with triplicated samples. However, the results (data not shown) indicated in all cases that neither cph nor pcph have exchanger activity on the H-ras protein.
The cph and pcph products are nucleotide-binding proteins
In addition to the GEFs, the cph and pcph proteins showed some partial homology to a second group of proteins. This group includes proteins as diverse as the human CD39 lymphoid activation antigen (GenBank/ EMBL accession number S73813), the GDA1 gene from the yeast Saccharomyces cerevisiae (L19506), the chicken cell membrane ecto ATPase (U74467), the pea NTPase (Z32743) and several unidenti®ed cosmids from Drosophila and C. elegans (AC002029, AC002035, U39652). The homology of these proteins with the cph and pcph was restricted to relatively short segments of their primary sequence (Figure 7b ) and ranged between 25 and 49% for polypeptide sequences of more than 30 amino acids. A common feature among these proteins is that most of them have nucleotide phosphatase (NPase) activities, although they show diverse substrate speci®cities and cleavage patterns. Initial attempts to measure some of these NPase activities with gel-puri®ed, in vitro translated cph and pcph proteins, or with whole TNT extracts used to synthesize cph or pcph yielded ambiguous, not consistently reproducible results, most likely because nucleotide pool heterogeneity among the various extracts used.
Although it was not possible to conclude whether the cph proteins had NPase activity, we reasoned that there was one property shared by GEFs and NPases: their ability to bind nucleotides, in particular ribonucleotides. Therefore, we tested whether the cph and pcph proteins were able to bind nucleotides in vitro. Gel puri®ed, in vitro translated cph and pcph proteins were immobilized on nitrocellulose membranes at various concentrations per well (between 5 and 10 pmol). Nucleotide binding was assessed using 3 Hlabeled nucleotides under conditions similar to those described in Materials and methods for the GDP loading of the H-ras protein in exchange activity assays. In fact, GDP binding to H-ras under similar conditions was used as a positive control for these experiments. Results showed that both cph and pcph proteins were able to bind only ribonucleotides, whereas similar concentrations of BSA did not show any binding capacity. Figure 7c shows data obtained on the binding of GDP by the cph proteins. Both cph proteins showed a greater binding capacity for ribonucleotide diphosphates in the following order: UDP4GDP4IDP4CDP, with no detectable binding for ADP or TDP. Binding to ribonucleotide triphosphates was signi®cantly lower, albeit detectable and ribonucleotide monophosphates did not seem to bind Figure 7 The polypeptide products of the cph oncogene and proto-oncogene are nucleotide-binding proteins. (a) The cph and pcph proteins have limited homology localized within the dbl homology (DH) domain of various members of the family of GDP/GTP exchange factors (GEFs); the best conserved residues are indicated in bold and were used to generate the consensus shown at the bottom. (b) In addition, the cph proteins also showed partial homology with a group of nucleotide phosphatases (NPases) in a region that overlaps with the region of GEF homology. Because the property common to GEFs and NPases is their nucleotide-binding activity, direct nucleotide binding assays were performed with gel-puri®ed cph and pcph proteins immobilized on nitrocellulose ®lters and 3 H-labeled nucleotides. Results (c) demonstrated that both cph and pcph are nucleotidebinding proteins; H-ras and BSA were used as positive and negative control proteins, respectively. Filters shown correspond to two independent nucleotide binding assays at all. The radiolabeled nucleotides dissociated from the immobilized proteins in the presence of excess concentrations of unlabeled nucleotides (20 ± 50 mM), indicating that the binding was speci®c. Essentially the same results were obtained using gel-puri®ed cph proteins or total cell-free extracts in which cph or pcph proteins had been in vitro translated. These results con®rmed that both cph and pcph are nucleotide-binding proteins.
Serum starvation upregulates cellular levels of cph mRNA
In the course of previous experiments designed to characterize the hyperactive neuregulin autocrine loop operating in chemically-initiated, 81C39 neoplastic Syrian hamster embryo cells (Avila et al., 1995; Velasco et al., 1998) , we maintained the cells in medium without serum for various periods of time to facilitate the puri®cation of polypeptides secreted into the culture¯uids. After serum starvation, we collected the cells, extracted RNA and performed northern hybridization analyses using cph cDNA probes. Results indicated (Figure 8a ) that in the absence of serum there was an upregulation in the expression of cph transcripts, and that the extent of upregulation was greater in the neoplastic cells (about 6.7-fold) than in normal cells (about 2.2-fold). Interestingly, there was a correlation between the extent of cph upregulation and the levels of neuregulin secreted into the media (Avila et al., 1995) . But more importantly, our results identi®ed cph as a serum deprivation-responsive gene (Gustincich and Schneider, 1993) , and placed it into a growing heterogeneous group of genes which share the property of being involved in the cellular response to stress (Liu et al., 1996; Rosette and Karin, 1996) . To our knowledge, cph and pcph are the ®rst nucleotidebinding proteins encoded by a sdr (serum deprivation response) gene.
Cells expressing the cph oncogene show increased resistance to various types of stress
If cph participates in the cellular response to stress, one could expect to see dierences in the response to various forms of stress between normal cells and those overexpressing cph or proto-cph. To test this possibility we used NIH3T3 cells transfected with the pCMV-CPH, pCMV-PCPH or pCDNA3 expression vectors described above. We seeded them in complete DMEM medium, containing 10% fetal bovine serum, at identical actual densities (appropriately corrected for their plating eciencies). After attachment, the plates were rinsed extensively with medium without serum, and then incubated in serum-free medium for up to 15 days. At various time points the medium was replaced with fresh serum-containing DMEM, and the surviving cells were stained with crystal violet usually 5 ± 7 days later. Results are shown in Figure 8b . Relative to vector (pCDNA3)-transfected cells, overexpression of the cph or proto-cph provided an obvious survival advantage for the cells to overcome serum starvation, with the oncogene being much more ecient at supporting cell survival than the proto-oncogene, suggesting that some cph-dependent events were involved in rendering the cells resistant to serum starvation. This was also strongly supported by results obtained from experiments in which cells expressing the cph or proto-cph were exposed to other forms of stress such as hyperthermia (Figure 8c ) or ionizing radiation (data not shown). Cells overexpressing cph were invariably more resistant to these forms of stress than those overexpressing proto-cph, and these more resistant than the vector-transfected, control cells. Similar results were obtained when at least three individual clones or pooled populations of cph-, proto-cph, or vector-transfected NIH3T3 were tested in these survival assays, indicating that the stress response was not due to clonal heterogeneity. More- Comparison between cells maintained in serum-containing or serum-free (sf) medium showed that serum starvation upregulates cellular levels of cph mRNA, and that the eect is greater in neoplastic than in normal cells; the full-length cph was used as the probe (a, top panel), and GAPDH was used to rehybridize the same blot as a loading control (a, bottom panel); the mobility of molecular size markers is indicated. (b) Cells (NIH3T3 ®broblasts) transformed by the cph oncogene (cph) showed a dramatically increased survival after two weeks of serum starvation relative to cells transfected with the cph proto-oncogene (proto-cph) and to cells transfected with empty expression vector (pcDNA3). (c) NIH3T3 cells transformed by the cph oncogene (empty columns) also showed enhanced survival after 72 h of exposure to hyperthermia relative to cells transfected with the pCMV-PCPH protooncogene expression vector (black columns) or with vector DNA alone (hatched columns) over, the induction of a generalized type of response by various forms of stress appeared to be speci®c for cph rather than a consequence of the oncogenic transformation of NIH3T3 cells. Results obtained from stressresponse experiments carried out with NIH3T3 cells transformed by other oncogenes (sis, fgr, ras, dbl, met) indicated that, although survival in serum-free medium was enhanced in some cases, transformation did not render the cells resistant to various forms of stress (data not shown). The generalized stress response elicited by cph led us to hypothesize that perhaps signaling through some of the known, central stress response pathways were being activated in cph-overexpressing cells, and that such signals were more eectively ampli®ed in cells expressing the cph oncogene. Ongoing experiments are designed to study the eect of cph on signaling via stress response pathways and to determine whether the response to stress mediated by cph proteins is modulated by their nucleotide binding activity.
Discussion
We described the identi®cation and cloning of fulllength cDNAs for the cph oncogene and protooncogene and established the mechanism of activation of the latter in Syrian hamster cells converted to the neoplastic state by carcinogen (MCA) treatment. The length of both clones and their ability to hybridize (Figure 1b) with the three transcripts typically detected in Syrian hamster embryo cells in culture and in most adult tissues with cph-speci®c probes (Velasco et al., 1996) , indicate that they derived from the smallest of the transcripts. Studies to con®rm the coding capacity of the cloned ORFs showed that the largest and most abundant cph and pcph polypeptides ( Figure 5c ) were consistent with translation initiation of both proteins at the ®rst ATG in the ORFs (Figure 2 ), in agreement with the fact that the ATG lays within a sequence context de®ned as favorable for translation initiation (Kozak, 1981) and the presence of an upstream, in frame translation termination codon (Figure 2) . Although the structural relationship between the three cph-speci®c transcripts remains unknown, it seems clear that molecular alterations of the smallest cph mRNA are sucient to confer the capacity to not only transform immortalized cells, but also to convert them into fully neoplastic and tumorigenic (Figure 3) .
The initial description of cph as a novel oncogene (Velasco et al., 1994) was based on two rather indirect pieces of information: the genomic cph clone (C-5) did not hybridize with probes speci®c for 42 dierent oncogenes, and the nucleotide sequence of extensive regions of the 42.5 kbp C-5 clone did not detect any homologous sequences in genome databases. Therefore, the cloning and sequencing of the cph and protocph full-length cDNAs provide direct con®rmation that cph is indeed a novel gene with oncogenic potential.
The mechanism of activation of cph in 81C39 cells, that is, the truncation of the normal ORF and the addition of a hydrophobic C-terminal tail (Figures 5 and 6, mutation 3) has been consistently found in other MCA-treated, neoplastic Syrian hamster cells. Although the transforming or tumorigenic potential of mutant cph forms truncated at nucleotide positions other than the one involved in the case of the 81C39 cells (i.e. mutants 2, 4 and 5 in Figure 6 ) remains to be established, it seems likely that they will be able also to convert cells to the malignant phenotype. Most of these mutations result essentially in the same structural consequences: loss of almost the C-terminal half of the normal pcph protein, and addition of a hydrophobic C-terminal tail of varying length.
On the basis of these structural changes, we postulated that the transforming activity of the cph protein was due to the deregulation of the normal activity caused by either the loss of putative regulatory sequences located towards the C-terminal half of the pcph protein, the addition of the C-terminal tail, or both. According to this notion, the structural determinants for such activity would be located Nterminally relative to the truncation point, being therefore shared by both cph and pcph. When compared with the GEFs, it seemed as if almost the entire cph protein were, except for the C-terminal tail, little more than a DH domain, with a particularly well conserved region (Figure 7) within the SCR3 subdomain (Boguski and McCormick 1993) . Interestingly, amino acid sequences in this region have been implicated directly in the GDP-GTP exchanger function of the db1 protein (Ron et al., 1991; Hart et al., 1994) . In particular, it is noteworthy that the triple Leu residues (starting at amino acid residue 144, Figure  2 ) are conserved in cph, because they have been shown to be intolerant to even conservative substitutions: both the exchanger activity and the transforming potential of dbl are lost upon deletion or mutagenesis of these sites (Ron et al., 1991; Hart et al., 1994) . This suggested that the normal cph protein might be a GEF.
It is widely known that Db1-related proteins work as exchangers on members of the Rho subfamily of small GDP/GTP-binding proteins (Narumiya, 1996) . However, cph and rho did not synergize in the transformation of NIH3T3 cells and cph did not catalyzed GDP/ GTP exchange on Rho protein puri®ed from bacteria (data not shown). The lack of exchanger activity of the cph proteins is consistent with the fact that they lack a PH domain, which is known to have a regulatory role for the activity of known GEFs (Haslam et al., 1993; Mayer et al., 1993; Quilliam et al., 1995) . Taking into consideration our previous ®nding that cph acts synergistically with H-ras to transform NIH3T3 cells (Velasco et al., 1994) , we tested whether cph might be a GEF for ras. This hypothesis was also consistent with the fact that, like cph, various GEFs had been isolated as oncogenes by their ability to transform NIH3T3 cells (Ron et al., 1988; Chan et al., 1994; Horii et al., 1994; Miki et al., 1995) . However, our results from nucleotide exchange assays indicated in all cases that cph proteins do not have exchanger activity on the Hras protein. One could argue that components present in the in vitro lysates or cellular extracts, or contaminating the gel-puri®ed proteins might have inhibited the GDP-exchange. However, it seemed unlikely that the exchanger activity of cph may be inhibited by components present in various cell extracts, whereas the activity of other known GEFs may be measured directly under similar conditions (Hart et al., 1994; Miki et al., 1995) . Nevertheless, we tested this possibility by assaying the exchange activity by an alternative method (Leonardsen et al., 1996) , but the data indicated again that cph did not catalyze GDP/GTP exchange on H-ras. Taken together, these results suggest that most likely cph proteins are not GEFs.
Interestingly, the cph and pcph proteins showed partial homology to a second family of proteins (Figure 7b ), all of which have nucleotide phosphohydrolase (NPase) activity although they dier in substrate speci®city and cleavage pattern. Attempts to measure whether the cph or pcph proteins had nucleotide phosphatase activity yielded ambiguous results. However, reasoning that GEFs and NPases must have the ability to bind nucleotides, ribonucleotides in particular, before exchanging or hydrolyzing them, it seemed logical to predict that the cph and pcph proteins might be able to bind nucleotides. Although the ribonucleotide-binding activities of cph and, specially, pcph are de®nitely lower than the one of ras, our results (Figure 7 ) demonstrated that both cph and pcph are indeed nucleotide-binding proteins, suggesting that such an activity may participate in their biological function. However, the mechanism of action of cph remains to be elucidated.
In this regard, it is important to note that we have shown previously that one of the most immediate phenotypic consequences of the endogenous (in Syrian hamster embryo cells) or heterologous (in NIH3T3 cells) expression of the cph oncogene is the establishment of a hyperactive autocrine loop mediated by the secretion of a neuregulin and the overexpression of the erbB4 or erbB2 neuregulin receptors (Avila et al., 1995; Velasco et al., 1998) . In the course of experiments designed to characterize this autocrine loop cells were maintained under conditions of serum deprivation. Northern hybridization analyses of RNA from serumdeprived cells indicated (Figure 8 ) that in the absence of serum there was an upregulation in the steady-state levels of cph transcripts, and that the extent of upregulation was greater in neoplastic than in normal cells. These results placed cph as a member of two expanding groups of genes: the serum deprivation responsive, sdr (Gustincich and Schneider, 1993) and the growth-arrest speci®c, gas (Brenner et al., 1989; Schneider et al., 1989; Lih et al., 1996) genes. Although these groups are rather heterogeneous and are formed by genes encoding proteins with diverse biological functions, they all share the property of being involved in the cellular response to stress. The notion that cph participates in cellular mechanisms of response to stress was greatly strengthened by our ®nding that expression of cph enhances the survival of NIH3T3 cells to various types of stress (Figure 8 ), a response similar to that observed previously (Notario et al., unpublished observations) for cph-transformed Syrian hamster embryo ®broblasts.
These data also suggested that the cph products interact with pathways known to signal in response to stress. Because various stress forms are known to signal through dierent pathways (Adler et al., 1995b; Kyriakis and Avruch, 1996; Lim et al., 1996) , it is possible that cph may participate in pathways involving the p38 and JNK/SAPK stress-activated kinases. This is an extremely attractive possibility, because the participation of cph in these pathways will also explain the synergism between ras and cph in transforming NIH3T3 cells (Velasco et al., 1994) , since ras is also capable of complexing and activating JNK (DeÂ rijard et al., 1994; Adler et al., 1995a; Minden et al., 1995) . Ongoing experiments are designed to study the eect of cph on signaling via stress response pathways, and to determine whether the response to stress mediated by cph proteins is modulated by their nucleotide binding activity.
Materials and methods
Cell lines and culture conditions
Normal Syrian hamster embryo cells (84-3) were obtained as described (Albor et al., 1994a) . The 81C39 transformed cell line was originated by treatment of 84-3 cultures with a single dose of the carcinogen MCA. Both cell types were routinely cultured in Dulbecco's modi®ed Eagle's medium (DMEM; Life Technologies, Gaithersburg, MD, USA) without phenol red and containing sodium bicarbonate (1.85 g/liter), sodium pyruvate (100 g/liter), 10% fetal bovine serum, 100 units/ml penicillin and 100 mg/ml streptomycin. The murine ®broblast NIH3T3 cell line was obtained from the American Type Cultured Collection (ATCC, Rockville, MD, USA) and the cells were maintained in regular DMEM supplemented with serum and antibiotics. For transfection experiments, NIH3T3 cells were carried in low-glucose (1 g/liter) DMEM.
RNA extraction and Northern blot hybridization analysis
Total cellular RNA was isolated as described (Chomczynski and Sacchi, 1987) . Poly(A + ) RNA was puri®ed using oligo-dT cellulose spin columns (Clontech, Palo Alto, CA, USA) as recommended by the manufacturers. RNA (20 mg of total or 2.5 mg of poly(A + ) RNA) was electrophoresed in 1% agarose gels under denaturing conditions (1.1 M formaldehyde, 50% formamide) and transferred by capillarity onto nitrocellulose membranes (Schleicher & Schuell, Keene, NH, USA). Hybridizations were performed under high stringency conditions in the presence of 50% formamide using the Wahl buer and cph speci®c probes of genomic or, later, cDNA origins. Blots were washed three times at room temperature in 26SSC, 0.1% SDS and twice at 428C in 0.16SSC, 0.1% SDS. After various autoradiographic exposures, the blots were reprobed with a radiolabeled GADPH or b-actin probes (from Clontech) to control equal loading and integrity of the RNA samples. Whenever relevant, relative transcript abundance was determined by densitometric analysis of the various autoradiographic exposures in a Howtek Scanner using PDI Discovery Series software for data processing.
cDNA cloning and sequencing
The cDNA for the cph oncogene was isolated from a library prepared from the neoplastic 81C39 cell line. Poly(A + ) RNA (5 mg) was reverse-transcribed and ligated into the l-ZAP-II vector (Stratagene, La Jolla, CA, USA). The library was packaged and 2.5610 5 independent clones were screened using the S6 cph-speci®c, genomic probe ( Figure 1a , Velasco et al., 1994) . Positive clones were recovered from the plaques by in vivo excision protocols with a helper ®lamentous phage and rescued as pBluescript SK + recombinant plasmids, in which the cDNA sequences are cloned directionally between the EcoRI and XhoI sites. After restriction endonuclease analysis, the pB1-19 cph cDNA clone was randomly selected for further structural and biological characterization. To clone the cDNA of the cph proto-oncogene, poly(A + ) RNA from normal 84-3 cells was used to prepare a library following the same protocol described above. The 84-3 cDNA library was screened with the insert puri®ed from the pB1-19 cph cDNA clone. A number of clones were isolated, and the longest one (pB1-843) was selected for further characterization. Nucleotide sequence determinations were carried out on both strands by automated DNA sequencing on a 377A sequencer (Perkin-Elmer Corp., Foster City, CA, USA). Portions of the sequences were con®rmed manually by the dideoxynucleotide chain-termination method using Sequenase (USB, Cleveland, OH, USA). Computer analyses of nucleotide and protein sequences and database searches were performed with the University of Wisconsin GCG software package.
In vitro coupled transcription-translation analysis
To verify the existence and coding capacity of the ORFs predicted from the nucleotide sequence of the cph and proto-cph cDNAs, we used a one-reaction system for the simultaneous transcription and translation of the inserted sequences. The system uses T3 or T7 RNA polymerase to transcribe the insert of interest and a rabbit reticulocyte extract for in vitro translation (TNT) systems, Promega Corp, Madison, WI, USA). On occasions, wheat-germ extracts (Promega Corp.) were used for in vitro translation. Reactions were performed in the presence of L-[ 35 S]methionine (Amersham, Arlington Heights, IL, USA), as previously described (Velasco et al., 1993) . Radiolabeled translation products were resolved by sodium dodecyl sulfate (SDS)-polyacrylamide (12.5%) gel electrophoresis (PAGE) and dried gels were exposed to X-ray ®lms to identify the protein speci®cally synthesized by the cph oncogene (cph) or proto-oncogene (pcph).
Transforming activity and tumorigenicity assays
Eukaryotic expression vectors for the cph and proto-cph cDNAs were constructed by ligating the Eco RI ± XhoI inserts of the pB1-19 and the pB1-843 plasmids into the EcoRI and XhoI sites of the mammalian expression vector pCDNA3 (Invitrogen Corp., San Diego, CA, USA) downstream from the promoter/enhancer sequences of the immediate early gene of the human cytomegalovirus (CMV). The resulting constructs were designated pCMV-CPH and pCMV-PCPH. Transfection experiments were carried out using the calcium phosphate precipitation method (Wigler et al., 1977; Notario et al., 1990) . The transforming activity of the cph cDNA was tested by transfection into NIH3T3 ®broblasts. Cells were maintained in low glucose DMEM and transfected with 1 mg of pCMV-CPH DNA. Transforming activity was assessed by the appearance of morphologically transformed foci, as described (Notario et al., 1990; Velasco et al., 1994) . Anchorage-independent growth was assayed by seeding 10 3 pCMV-CPH-transformed cells per 35-mm plate into regular DMEM medium containing 0.33% noble agar (Difco Laboratories, Detroit, MI, USA). Cells transfected with pCMV-PCPH and pCDNA3 were selected in the presence of G-418 (400 mg/ml) and used as controls for transformation, anchorage-independent growth and tumorigenicity assays. Tumorigenicity tests were carried out by subcutaneous injection into the¯anks of 4-week-old, female, nude mice of 10 7 cells transformed by pCMV-CPH, or transfected with pCMV-PCPH or pCDNA3. Groups of ®ve mice were injected in both¯anks with each of the three cell types. Tumor formation was monitored regularly and, after 6 weeks, tumors were excised from the animals. About one third of each tumor was snap-frozen in liquid nitrogen for molecular characterization, one third was used to establish the tumor cells in culture, and one third was ®xed in 4% formaldehyde, embedded in paran and used for histopathological examination after hematoxylin and eosin staining of 5 mm-thick sections.
GDP/GTP exchange assays
Guanine nucleotide exchange was assayed as described (Self and Hall, 1995; Zheng et al., 1995) with some modi®cations. Bacterial recombinant human H-ras protein (Panvera Corp., Madison, WI, USA) was incubated with [8,5'- 3 H]GDP (15 Ci/mmol, NEN Life Science Products, Boston, MA, USA). at a molar ratio of 1 : 10, for 60 min at 328C, in loading buer containing 20 mM Tris-HCl pH 7.5, 1 mM MgCl 2 , 1 mM DTT, 100 mM NaCl and 40 mg/ml BSA.
3 H-GDP-loaded recombinant H-ras protein was stabilized with 12 mM MgCl 2 , immobilized by ®ltration through a 0.45 mm nitrocellulose membrane using a dotblot apparatus (Schleicher & Schuell), and washed three times with 25 mM Tris-HCl, pH 7.5, 100 mM NaCl and 12 mM MgCl 2 to remove excess free [
3 H]GDP. The nitrocellulose circles corresponding to the wells of the micro®ltration apparatus (about 3 mm diameter) were cut out, and their initial 3 H-label determined by scintillation counting. The amount of [ 3 H]GDP-Ras bound for each piece of nitrocellulose was about 10 5 c.p.m. Each circle contained about 14 pmol of Ras-GDP complex. Exchange reactions were initiated by incubating the circles with 150 ml of exchange buer (Bustelo et al., 1994; Gulbins et al., 1994a,b; Miki et al., 1995) containing either cell-free extracts used for the in vitro synthesis of the cph or pcph proteins or gel-puri®ed, in vitro translated cph or pcph proteins (1 ± 5 pmol), plus 50 mM GTP. Reactions were incubated at 378C for up to 60 min. Aliquots were removed at various times, and the amount of [ 3 H]GDP released was determined by liquid scintillation counting. Alternatively, nucleotide exchange activity assays were also performed as described by Leonardsen et al. (1996) .
Gel puri®cation of in vitro translated proteins
In vitro coupled transcription/translation reactions were carried out as described above, but every reaction was scaled up twofold, and two sets of 20 replicated reactions were performed to synthesize the cph protein or the pcph protein. For each set of reactions, only one of them was carried out in the presence of L-[
35 S]methionine. The in vitro translated products were resolved by preparative SDS ± PAGE, loading the radiolabeled samples on the outside lanes at both ends of the gels. After electrophoresis, the gels were`renatured' as described (Scovassi et al., 1984) . SDS was removed by washing the gels twice, with one liter each time, in 50 mM Tris-HCl pH 8.0 and 3 mM 2-mercaptoethanol (renaturation buer) for 2 h at room temperature. Proteins were renatured by treating the gels with 6 M guanidine-HCl in renaturation buer (two changes of 100 ml each) and then with renaturation buffer (®ve changes of 1 liter each) at 28C over a period of 16 ± 18 h. The`renatured' gels were exposed to X-ray ®lm without drying, and the cph or pcph bands were excised from the gel using the signal in the radiolabeled lanes as guidance. The cph and pcph proteins were electroeluted from the pieces of gel and concentrated using Centricon microconcentrator units (Amicon, Beverly, MA, USA). Gel-puri®ed proteins were used for exchange assays and for assays to measure nucleotide binding.
Nucleotide binding assays
Assays to detect nucleotide binding to gel-puri®ed cph and pcph proteins were carried out withthe H-ras protein, in a dot-blot apparatus, instead of performing solution-binding assays followed by ®ltration through a syringe-attached ®lter unit. Alternatively, nucleotide binding was determined by ultra®ltration assays carried out as described (OrmoÈ and SjoÈ berg, 1990) .
Cell survival assays
NIH3T3 cells transformed by the pCMV-CPH construct or transfected with pCMV-PCPH or pCDNA3 (either individual clones or pooled populations) were seeded into 10 cm-dishes, in complete DMEM medium (with 10% fetal bovine serum), at the same density (5610 5 cells per dish), corrected for their relative plating eciency. The cells were incubated overnight under standard culture conditions. The next morning the medium was aspirated, the cells were washed ®ve times with serum-free DMEM, 10 ml of serumfree DMEM were added to every dish, and the cultures were incubated again. After serum-starvation periods of up to 2 weeks, the medium was changed back to complete DMEM, and the cultures were maintained in serumcontaining medium until surviving colonies were of an appropriate size to be quanti®ed by staining with 1% crystal violet in 70% ethanol. Experiments with Syrian hamster normal (84-3) and neoplastic (81C39) cells were performed under similar conditions. The eect of hyperthermia on cell survival was studied by incubating sparsely seeded cultures (1 ± 5610 3 cells per 10 cm-dish), in serum-containing medium, at various temperatures (up to 458C) for up to 72 h. All cultures were then returned to 378C and maintained until surviving colonies could be stained and quanti®ed as described above. Radiation survival was determined from clonogenic assays performed as described (Stevens et al., 1995) .
